The ReadoutJoi Ito quits PureTech & lung cancer drugs impress By Meghana Keshavan Sept. 9, 2019 Reprints Alex Hogan/STAT The Readout for September 09, 2019 About the Author Reprints Meghana Keshavan Biotech Correspondent Meghana Keshavan covers biotech and contributes to The Readout newsletter. [email protected] @megkesh
The Readout Meghana Keshavan Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
The Readout Damian Garde Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Exclusive Rachel Cohrs STAT Plus: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals
Matt's Take Matthew Herper STAT Plus: Battle for the soul of Illumina is also a referendum on its CEO
Health Isabella Cueto and Olivia Goldhill STAT Plus: Ketamine clinics’ bust serves as warning of business challenge facing psychedelic therapy